Vitamin B1 for depression in children and teens
Part of Mental health clinical trials.
This study tests whether taking vitamin B1 (thiamine) by mouth can help reduce depression symptoms in children and teenagers aged 8 to 17.5 years. It is a 12-week trial that involves taking a daily pill and completing questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 8 and 17.5 years old.
- You have been diagnosed with major depressive disorder (depression).
- Your depression symptoms are mild to moderate (not severe).
- You and your parent/guardian can speak and read English.
- You can swallow pills and have access to a computer with camera and internet.
- You are not currently taking certain psychiatric medications (like antipsychotics or sedatives) and your depression treatment has been stable for at least 6 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether vitamin D supplements can improve brain wave patterns in women diagnosed with depression who have low vitamin D levels. Researchers will measure brain activity using EEG (a non-invasive test that records electrical signals from the brain) before and after vitamin D treatment.
This trial tests whether a non-invasive brain stimulation technique called deep transcranial magnetic stimulation (dTMS) can help teens with moderate to severe depression feel better. It involves wearing a special magnetic coil on the head during several sessions.
This study uses brain scans to look at dopamine — a chemical messenger related to reward and mood — in people with depression and healthy volunteers. Researchers want to understand how dopamine changes in depression, which may lead to better treatments.
This trial tests a new medicine called DT-101 to see if it helps people with depression. It is for adults who have had more than one depressive episode in their life.
This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms over time. Participants must stop other depression medications before starting and will be monitored closely.
This study tests a medication called bupropion (an antidepressant) in children and teens with depression. It aims to see if it is safe and effective for this age group.
Hear when a new Pediatrics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.